Literature DB >> 619839

The effects of hyperbaric and normobaric oxygen on cognitive impairment in the elderly.

A Raskin, S Gershon, T H Crook, G Sathananthan, S Ferris.   

Abstract

Eighty-two elderly subjects with significant cognitive impairment were randomly assigned to treatment with either hyperbaric oxygen, hyperbaric air, normobaric oxygen, or normobaric air. Treatment consisted of two 90-minute sessions a day for 15 consecutive days. Subjects were evaluated on measures of memory and intellectual capacity, as well as on psychiatric symptom rating scales. Results immediately after treatment and at one, two, three, and eight weeks following treatment did not show enhanced cognitive functioning or significantly greater symptom reduction in experimental subjects who received either normobaric or hyperbaric oxygen as compared to controls who received hyperbaric or normobaric air. There was also no evidence of differential treatment effects as a function of initial severity of illness, sex, response to a CO2 loading test, or presumed evidence of cerebrovascular disease.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 619839     DOI: 10.1001/archpsyc.1978.01770250052005

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  8 in total

Review 1.  Critical review of clinical trials in senile dementia--II.

Authors:  J M Orgogozo; R Spiegel
Journal:  Postgrad Med J       Date:  1987-05       Impact factor: 2.401

Review 2.  The BEHAVE-AD assessment system: a perspective, a commentary on new findings, and a historical review.

Authors:  Barry Reisberg; Isabel Monteiro; Carol Torossian; Stefanie Auer; Melanie B Shulman; Santosh Ghimire; Istvan Boksay; Francoise Guillo BenArous; Ricardo Osorio; Aninditha Vengassery; Sheema Imran; Hussam Shaker; Sadaf Noor; Shazia Naqvi; Sunnie Kenowsky; Jinfeng Xu
Journal:  Dement Geriatr Cogn Disord       Date:  2014-04-07       Impact factor: 2.959

Review 3.  Integrative Role of Hyperbaric Oxygen Therapy on Healthspan, Age-Related Vascular Cognitive Impairment, and Dementia.

Authors:  Priya Balasubramanian; Jordan Delfavero; Adam Nyul-Toth; Amber Tarantini; Rafal Gulej; Stefano Tarantini
Journal:  Front Aging       Date:  2021-09-23

Review 4.  Hyperbaric oxygen therapy for healthy aging: From mechanisms to therapeutics.

Authors:  Qiaoyu Fu; Ran Duan; Yu Sun; Qingfeng Li
Journal:  Redox Biol       Date:  2022-05-27       Impact factor: 10.787

Review 5.  Metabolic agents that enhance ATP can improve cognitive functioning: a review of the evidence for glucose, oxygen, pyruvate, creatine, and L-carnitine.

Authors:  Lauren Owen; Sandra I Sunram-Lea
Journal:  Nutrients       Date:  2011-08-10       Impact factor: 5.717

6.  A double-blind placebo-controlled clinical trial testing the effect of hyperbaric oxygen therapy on brain and cognitive outcomes of mildly cognitively impaired elderly with type 2 diabetes: Study design.

Authors:  Ori BenAri; Shai Efrati; Mary Sano; Barbara B Bendlin; HungMo Lin; Xiaoyu Liu; Inbar Sela; Ganit Almog; Abigail Livny; Israel Sandler; Simona Ben-Haim; Roy Sagi; Derek LeRoith; Michal Schnaider Beeri; Ramit Ravona-Springer
Journal:  Alzheimers Dement (N Y)       Date:  2020-04-13

Review 7.  Hyperbaric Oxygen Treatment-From Mechanisms to Cognitive Improvement.

Authors:  Irit Gottfried; Nofar Schottlender; Uri Ashery
Journal:  Biomolecules       Date:  2021-10-15

Review 8.  Impact of Hyperbaric Oxygen Therapy on Cognitive Functions: a Systematic Review.

Authors:  Anna B Marcinkowska; Natalia D Mankowska; Jacek Kot; Pawel J Winklewski
Journal:  Neuropsychol Rev       Date:  2021-04-13       Impact factor: 7.444

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.